Now that Enovis Corp’s volume has hit 0.89 million, investors get a glimpse of its size.

Enovis Corp (NYSE: ENOV) on Tuesday, soared 3.01% from the previous trading day, before settling in for the closing price of $29.55. Within the past 52 weeks, ENOV’s price has moved between $25.47 and $49.83.

A company in the Healthcare sector has dropped its sales by -4.65% annually for the last half of the decade. The company achieved an average annual earnings per share of 10.18%. With a float of $55.92 million, this company’s outstanding shares have now reached $57.16 million.

In an organization with 7367 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 69.79%, operating margin of -51.25%, and the pretax margin is -51.87%.

Enovis Corp (ENOV) Insider Updates

Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of Enovis Corp is 2.16%, while institutional ownership is 119.06%. The most recent insider transaction that took place on Aug 13 ’25, was worth 289,000. In this transaction EVP, Strategy & Business Dev. of this company bought 10,000 shares at a rate of $28.90, taking the stock ownership to the 161,115 shares.

Enovis Corp (ENOV) Performance Highlights and Predictions

As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported 0.73 earnings per share (EPS) for the period topping the consensus outlook (set at 0.61) by 0.12. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.86 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 10.18% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 12.25% during the next five years compared to -4.65% drop over the previous five years of trading.

Enovis Corp (NYSE: ENOV) Trading Performance Indicators

Enovis Corp (ENOV) is currently performing well based on its current performance indicators. A quick ratio of 1.15 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.79.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -14.78, a number that is poised to hit 0.65 in the next quarter and is forecasted to reach 3.48 in one year’s time.

Technical Analysis of Enovis Corp (ENOV)

Let’s dig in a bit further. During the last 5-days, its volume was 1.12 million. That was inferior than the volume of 1.2 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 87.87%.

During the past 100 days, Enovis Corp’s (ENOV) raw stochastic average was set at 36.01%, which indicates a significant decrease from 97.64% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.20 in the past 14 days, which was lower than the 1.39 volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $30.24, while its 200-day Moving Average is $37.99. However, in the short run, Enovis Corp’s stock first resistance to watch stands at $30.81. Second resistance stands at $31.18. The third major resistance level sits at $31.80. If the price goes on to break the first support level at $29.82, it is likely to go to the next support level at $29.20. Assuming the price breaks the second support level, the third support level stands at $28.83.

Enovis Corp (NYSE: ENOV) Key Stats

Market capitalization of the company is 1.74 billion based on 57,160K outstanding shares. Right now, sales total 2,108 M and income totals -825,490 K. The company made 564,550 K in profit during its latest quarter, and -36,740 K in sales during its previous quarter.